Capsida Biotherapeutics to Present at 7th Annual Evercore HealthCONx Conference
Capsida Biotherapeutics ("Capsida"), a leading fully integrated next-generation gene therapy company developing treatments for rare and common diseases across all ages, today announced that the company will present at the 7(th) Annual Evercore HealthCONx Conference being held December 3-5,
Rocket Pharmaceuticals to Participate in the 7th Annual Evercore HealthCONx Conference
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that the Company will participate in the 7 th Annual Evercore HealthCONx Conference in Miami,
1don MSN
Sarah Bianchi, Evercore ISI public policy chief strategist, joins 'Squawk Box' to discuss President-elect Trump's nomination ...
The Wisconsin-based company reported a same-store sales decline of 9.3% – its eleventh same-store sales decline in a row.
Julian Emanuel, chief equity and quantitative strategist at Evercore ISI, sees markets in a "digestion phase" following the ...
Roger Altman, former deputy Treasury secretary and founder of Evercore, joins CNBC's 'Squawk Box' to discuss president-elect ...
Kohl’s surprise CEO departure announcement a day before its quarterly results will play on the minds of investors, who were ...
"While we heard from many retailers last week about quarter to date accelerations, we don't think an abrupt CEO departure is ...
The live webcast for the Evercore fireside chat will be accessible through the “Events” section of the Investor Relations tab within ProKidney’s website at www.prokidney.com. Investors interested in ...
We recently compiled a list of the 15 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...
Starting in 2021 an employee hid $132 million to $154 million in delivery expenses, a disclosure overshadowing an otherwise ...
is scheduled to participate in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference on Tuesday, Dec. 3, ...
Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences: ...
Evercore ISI analyst Chris McNally maintained a Buy rating on Aptiv (APTV – Research Report) today and set a price target of $105.00. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback